Map-dot-fingerprint Dystrophy Medication

Updated: Feb 14, 2019
  • Author: David D Verdier, MD; Chief Editor: Hampton Roy, Sr, MD  more...
  • Print

Medication Summary

The goals of pharmacotherapy are to reduce morbidity and to prevent complications.


Hyperosmolar agents

Class Summary

Create osmotic gradient that draws water out of the cornea.

Sodium chloride hypertonic, ophthalmic (Muro 128, AK-NaCl)

Used for temporary relief of corneal edema. May improve corneal epithelial adhesion and irregular corneal astigmatism.